When the medication isn't working
Zepbound Not Working? Doses, Timelines, and What to Do
If Zepbound is not working for your weight yet, compare your dose and time on treatment to the label, rule out practical problems like missed doses and storage, and bring a clear record to your prescriber.
Last reviewed
The Vital angle
Vital logs each Zepbound dose with the date, amount, and site, so you can see when you left the 2.5 mg start, when you reached maintenance, and which weeks you missed. Your weight trend from Apple Health sits next to that history, which turns the 12-weeks-on-full-dose check into something you and your prescriber can read at a glance.
Zepbound (tirzepatide) produced some of the largest average weight loss numbers seen in obesity trials. That is part of why "Zepbound not working" is such a common search. When the average result is about 20 percent, a slower first few months can feel like failure. Usually it is not. The dose ladder is long, the 2.5 mg start is not a treatment dose, and the scale is noisy week to week.
This guide shows what the Zepbound label says to expect, how to separate a slow start from a weak response, and what to bring to your prescriber. It does not tell you to change your dose. That decision is theirs.
What Zepbound is approved for
Zepbound is approved, together with a reduced-calorie diet and more physical activity, for two uses in adults:
- To reduce excess body weight and keep it off long term in adults with obesity, or with overweight and at least one weight-related health problem.
- To treat moderate to severe obstructive sleep apnea in adults with obesity.
If you take Zepbound for sleep apnea, judge it by your sleep symptoms and follow-up sleep testing with your clinician, not only by weight. The label also says not to use Zepbound with other tirzepatide products or with any GLP-1 drug. If you are on two of these at once, ask your prescriber.
The 2.5 mg start is not a maintenance dose
The label is direct about this: the 2.5 mg dose is for starting treatment and is not approved as a maintenance dose. The schedule is:
- 2.5 mg once a week for 4 weeks.
- Then 5 mg once a week.
- If needed, increase by 2.5 mg after at least 4 weeks on the current dose.
- Maintenance for weight is 5 mg, 10 mg, or 15 mg. The maximum is 15 mg.
If you feel little in the first month, you are on the dose that is meant to help your stomach adjust. The weight results in the label trials come from 5 mg, 10 mg, and 15 mg. For the first weeks in general, see GLP-1 not working in the first month.
What a normal response looks like
In the main 72-week trial in the label, adults without diabetes lost on average:
| Dose | Average weight change | Lost at least 5% |
|---|---|---|
| Placebo | 3.1% | 34.5% |
| 5 mg | 15.0% | 85.1% |
| 10 mg | 19.5% | 88.9% |
| 15 mg | 20.9% | 90.9% |
In a second 72-week trial in adults with type 2 diabetes, average loss was 12.8 percent on 10 mg and 14.7 percent on 15 mg.
What this means for you:
- About 1 in 10 people did not reach 5 percent loss even at the higher doses. A weaker response exists and is not your fault.
- People with type 2 diabetes tend to lose less.
- The trial ran for 72 weeks. Most of the curve flattens in the second half. If your loss slowed after a strong start, read weight loss plateaus.
How long to give it
The NIDDK advises that if you are not losing weight after 12 weeks on the full dose of a weight management medication, you should ask your health care professional whether to stop. With Zepbound, "full dose" means your maintenance dose, not 2.5 mg.
A clean way to measure:
- Weigh yourself at the same time of day, a few times a week.
- Look at a 4-week average, not single readings.
- Mark the date you reached your maintenance dose.
- Track loss from your start and loss from that date.
Daily weight can move 1 to 3 pounds from water, salt, and digestion alone, so a flat week is not data yet.
Practical problems to rule out
Before you and your prescriber talk about changes, check the routine.
Missed doses. The label gives a 4-day (96-hour) window to take a missed dose, and it says what to do after that window. It also says two doses must be at least 3 days (72 hours) apart if your dose day changes. Ask your pharmacist if you are not sure which rule applies to you. See missed GLP-1 dose.
Storage. Keep Zepbound refrigerated at 36°F to 46°F and do not freeze it. Single-dose pens and vials can stay unrefrigerated up to 86°F for a total of 21 days. The label says to throw away an opened multi-dose vial or KwikPen after 30 days at room temperature, 30 days after first use, or after 4 weekly doses, even if medicine is left. If a pen froze or got hot, ask your pharmacist. See GLP-1 left out of the fridge.
Pen or vial technique. If you use vials, measuring with a syringe adds a place for error. Ask your pharmacist to check your technique once. If your pen does not seem to inject, see Zepbound pen not working.
Compounded tirzepatide. The FDA has not approved compounded tirzepatide. It has received hundreds of adverse event reports linked to compounded tirzepatide, some of which may relate to doses beyond the approved label. If you switched products and your results changed, tell your prescriber what you use.
Eating patterns. Less hunger can still leave room for drinks, alcohol, and snacks. A short period of honest food logging often shows the gap. Keep protein steady so you lose fat, not muscle. See protein on GLP-1.
Oral birth control and Zepbound
Zepbound slows stomach emptying. The label advises people who use oral hormonal birth control to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. This matters for pregnancy prevention, and the label says to stop Zepbound when pregnancy is recognized. Ask your prescriber or pharmacist which method fits you.
Talking to your prescriber
Plan a visit if:
- You have had about 12 weeks on your maintenance dose with little or no loss.
- You had good loss and are now regaining on the same dose.
- Side effects keep you from moving up or from staying on your current dose.
- You want to know whether 5 mg, 10 mg, or 15 mg fits your goal.
Bring the date and dose of each injection, missed weeks, your weight trend, side effects with how bad they were, and your full medicine list. Your prescriber can then judge whether you need more time, a different maintenance dose, help with side effects, or a different plan. If hunger comes back late in the week, see food noise back on GLP-1. If you think the drug used to work and stopped, see GLP-1 stopped working.
Warning signs that need care now
Get medical care right away for:
- Severe stomach pain that does not go away, with or without vomiting.
- Upper right belly pain, fever, yellow skin or eyes, or clay-colored stool.
- Swelling of the face, lips, tongue, or throat, trouble breathing, or a severe rash.
- Vomiting or diarrhea that stops you from keeping fluids down, or much less urine than usual.
- A sudden decrease or loss of vision in one eye.
- Shaking, sweating, or confusion from low blood sugar, mostly if you also use insulin or a sulfonylurea.
- A lump in the neck, trouble swallowing, or lasting hoarseness.
Zepbound®, KwikPen® are trademarks of Eli Lilly and Company. Vital is independent and not affiliated with these companies.
Things to watch
Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.
Judging Zepbound on 2.5 mg
The label says 2.5 mg is for starting treatment and is not approved as a maintenance dose. Weight results in the trials came from 5 mg, 10 mg, and 15 mg.
Comparing to the 20 percent headline
The 20.9 percent average came from 15 mg over 72 weeks in adults without diabetes. Lower doses, shorter time, and type 2 diabetes all predict smaller averages.
Missed doses past 4 days
The label gives a 4-day window to take a missed dose. Repeated gaps can bring hunger back and slow loss.
Using an opened multi-dose pen too long
The label says to throw away an opened multi-dose vial or KwikPen after 30 days at room temperature, 30 days after first use, or 4 weekly doses, even if medicine is left.
Combining Zepbound with another GLP-1 product
The label says not to use Zepbound with other tirzepatide products or any GLP-1 drug. Tell your prescriber about every product you use.
Sudden vision loss in one eye
The label lists NAION, a sudden decrease or loss of vision in one eye, as reported with GLP-1 drugs. Get eye care right away.
Frequently asked questions
Zepbound starts at 2.5 mg for 4 weeks, then 5 mg, with possible 2.5 mg steps after at least 4 weeks on each dose. The trial weight results come from 5 mg, 10 mg, and 15 mg. The NIDDK suggests judging a weight medication after 12 weeks on the full dose.
The label says 2.5 mg is a starting dose and is not approved as a maintenance dose. It helps your body adjust. Weight results in the trials came from 5 mg, 10 mg, and 15 mg.
In the main 72-week trial, about 85 to 91 percent of adults without diabetes lost at least 5 percent of body weight, depending on dose. So roughly 1 in 10 did not. Adults with type 2 diabetes lost less on average.
Loss usually slows in the second half of the first year as your body adjusts to a lower weight. Check for missed doses and storage problems, then bring your trend to your prescriber, who can decide whether a different maintenance dose fits you.
In the label trial, 5 mg led to about 15 percent average loss over 72 weeks, and 5 mg is an approved maintenance dose. Whether it is enough for you depends on your goals and response, which is a prescriber question.
Yes. The label advises a non-oral method or an added barrier method for 4 weeks after starting and for 4 weeks after each dose increase, because Zepbound can lower how well oral contraceptives work.
Sources
- ZEPBOUND (tirzepatide) injection Prescribing Information · Eli Lilly and Company
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) · New England Journal of Medicine
- Prescription Medications to Treat Overweight & Obesity · NIDDK, National Institutes of Health
- Tirzepatide (subcutaneous route) · Mayo Clinic
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration
This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.
Track every shot, every change
Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.
More from the Library
Compounded vs Brand Semaglutide
Compounded semaglutide and brand-name Wegovy or Ozempic are not the same product. A clear-eyed look at the actual differences in regulation, formulation, cost, and risk.
Food Noise Coming Back on a GLP-1: End-of-Week Hunger and What to Track
Food noise coming back on a GLP-1 can follow the dose week, a dose step, stress, or a product change. Here is what is known, what to track for two to four weeks, and what to ask your prescriber.
Tirzepatide Medication Level Chart: Half-Life, Steady State, and Missed Doses
A tirzepatide medication level chart and a semaglutide level chart built from label half-lives, with tables for one dose, the build-up to steady state, the weekly rise and fall, and a missed dose.
GLP-1 Not Working in the First Month: What Is Normal
Little or no weight loss in the first month on a GLP-1 is common, because the starting doses are low by design. Here is what the first weeks are for, what to watch, and when to call your prescriber.